Legal & General Group
KZR

Legal & General Group’s Kezar Life Sciences KZR Stock Holding History

Legal & General Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-681
Closed -$6.14K – 3470
2024
Q1 		$6.14K Hold
681
– – ﹤0.01% 3276
2023
Q4 		$6.46K Hold
681
– – ﹤0.01% 3298
2023
Q3 		$8.11K Hold
681
– – ﹤0.01% 3304
2023
Q2 		$16.7K Sell
681
-4
-0.6% -$104 ﹤0.01% 3183
2023
Q1 		$21.4K Sell
685
-1,098
-62% -$63.5K ﹤0.01% 3050
2022
Q4 		$126K Buy
1,783
+100
+6% +$7.42K ﹤0.01% 2764
2022
Q3 		$145K Buy
1,683
+190
+13% +$18.5K ﹤0.01% 2721
2022
Q2 		$123K Buy
1,493
+1,186
+386% +$105K ﹤0.01% 2794
2022
Q1 		$51K Buy
307
+28
+10% +$4.02K ﹤0.01% 2997
2021
Q4 		$47K Hold
279
– – ﹤0.01% 3042
2021
Q3 		$24K Hold
279
– – ﹤0.01% 3216
2021
Q2 		$15K Hold
279
– – ﹤0.01% 3378
2021
Q1 		$17K Hold
279
– – ﹤0.01% 3187
2020
Q4 		$15K Hold
279
– – ﹤0.01% 3200
2020
Q3 		$13K Sell
279
-35
-11% -$1.67K ﹤0.01% 3126
2020
Q2 		$16K Sell
314
-63
-17% -$3.18K ﹤0.01% 3155
2020
Q1 		$16K Buy
377
+163
+76% +$6.63K ﹤0.01% 2994
2019
Q4 		$9K Hold
214
– – ﹤0.01% 3305
2019
Q3 		$7K Hold
214
– – ﹤0.01% 3303
2019
Q2 		$15K Hold
214
– – ﹤0.01% 3279
2019
Q1 		$38K Buy
214
+136
+174% +$26.8K ﹤0.01% 2817
2018
Q4 		$18K Hold
78
– – ﹤0.01% 3117
2018
Q3 		$17K Buy
+78
New +$13.6K ﹤0.01% 3248

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Legal & General Group's KZR Position: Q2 2024 in Review

Legal & General Group sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 681 shares — an estimated $6.14K sold.

Legal & General Group first reported a position in KZR in Q3 2018 and held it in 23 quarters. The position peaked at $145K in Q3 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Legal & General Group reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 681 Kezar Life Sciences shares in Q2 2024, an estimated $6.14K.
  • Legal & General Group first reported a position in Kezar Life Sciences in Q3 2018 and held it in 23 quarters.
  • Legal & General Group's Kezar Life Sciences position peaked at $145K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.